SEC Form 4 · accession 0001878313-26-000087
MAIA Biotechnology, Inc. · MAIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vlad Vitoc
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Sep 14, 2026
Accepted (ET)
Sep 15, 2026 · 6:33 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001878313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | P | 73,000 | $1.37 | A | 1,049,121 | D | |
| Common StockF1 | holding | — | — | — | 210,100 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.